Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Colonoscopy-Related Mortality in a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program.
Kooyker AI, Toes-Zoutendijk E, Opstal-van Winden AWJ, Buskermolen M, van Vuuren HJ, Kuipers EJ, van Kemenade FJ, Ramakers C, Dekker E, Nagtegaal ID, de Koning HJ, Spaander MCW, Lansdorp-Vogelaar I, van Leerdam ME. Kooyker AI, et al. Among authors: ramakers c. Clin Gastroenterol Hepatol. 2021 Jul;19(7):1418-1425. doi: 10.1016/j.cgh.2020.07.066. Epub 2020 Aug 7. Clin Gastroenterol Hepatol. 2021. PMID: 32777553 Free article.
Equivalent Accuracy of 2 Quantitative Fecal Immunochemical Tests in Detecting Advanced Neoplasia in an Organized Colorectal Cancer Screening Program.
Wieten E, de Klerk CM, van der Steen A, Ramakers CR, Kuipers EJ, Hansen BE, Lansdorp-Vogelaar I, Bossuyt PM, Dekker E, Spaander MCW. Wieten E, et al. Among authors: ramakers cr. Gastroenterology. 2018 Nov;155(5):1392-1399.e5. doi: 10.1053/j.gastro.2018.07.021. Epub 2018 Jul 25. Gastroenterology. 2018. PMID: 30055170
Quality Monitoring of a FIT-Based Colorectal Cancer Screening Program.
Toes-Zoutendijk E, Bonfrer JMG, Ramakers C, Thelen M, Spaander MCW, Dekker E, van der Meulen MP, Buskermolen M, van Vuuren AJ, Kuipers EJ, van Kemenade FJ, van Velthuysen MF, Thomeer MGJ, van Veldhuizen H, van Ballegooijen M, de Koning HJ, van Leerdam ME, Lansdorp-Vogelaar I. Toes-Zoutendijk E, et al. Among authors: ramakers c. Clin Chem. 2019 Mar;65(3):419-426. doi: 10.1373/clinchem.2018.294041. Epub 2019 Jan 16. Clin Chem. 2019. PMID: 30651228
Incidence of Interval Colorectal Cancer After Negative Results From First-Round Fecal Immunochemical Screening Tests, by Cutoff Value and Participant Sex and Age.
Toes-Zoutendijk E, Kooyker AI, Dekker E, Spaander MCW, Opstal-van Winden AWJ, Ramakers C, Buskermolen M, van Vuuren AJ, Kuipers EJ, van Kemenade FJ, Velthuysen MF, Thomeer MGJ, van Veldhuizen H, van Ballegooijen M, Nagtegaal ID, de Koning HJ, van Leerdam ME, Lansdorp-Vogelaar I; Dutch National Colorectal Cancer Screening Working Group. Toes-Zoutendijk E, et al. Among authors: ramakers c. Clin Gastroenterol Hepatol. 2020 Jun;18(7):1493-1500. doi: 10.1016/j.cgh.2019.08.021. Epub 2019 Aug 20. Clin Gastroenterol Hepatol. 2020. PMID: 31442598 Free article.
The second round of the Dutch colorectal cancer screening program: Impact of an increased fecal immunochemical test cut-off level on yield of screening.
Kooyker AI, Toes-Zoutendijk E, Opstal-van Winden AWJ, Spaander MCW, Buskermolen M, van Vuuren HJ, Kuipers EJ, van Kemenade FJ, Ramakers C, Thomeer MGJ, Dekker E, Nagtegaal ID, de Koning HJ, van Leerdam ME, Lansdorp-Vogelaar I. Kooyker AI, et al. Among authors: ramakers c. Int J Cancer. 2020 Aug 15;147(4):1098-1106. doi: 10.1002/ijc.32839. Epub 2020 Jan 9. Int J Cancer. 2020. PMID: 31853977 Free PMC article.
Colorectal cancer incidence, mortality, tumour characteristics, and treatment before and after introduction of the faecal immunochemical testing-based screening programme in the Netherlands: a population-based study.
Breekveldt ECH, Lansdorp-Vogelaar I, Toes-Zoutendijk E, Spaander MCW, van Vuuren AJ, van Kemenade FJ, Ramakers CRB, Dekker E, Nagtegaal ID, Krul MF, Kok NFM, Kuhlmann KFD, Vink GR, van Leerdam ME, Elferink MAG; Dutch National Colorectal Cancer Screening Working Group. Breekveldt ECH, et al. Among authors: ramakers crb. Lancet Gastroenterol Hepatol. 2022 Jan;7(1):60-68. doi: 10.1016/S2468-1253(21)00368-X. Epub 2021 Nov 22. Lancet Gastroenterol Hepatol. 2022. PMID: 34822762
Faecal occult blood loss accurately predicts future detection of colorectal cancer. A prognostic model.
Meester RGS, van de Schootbrugge-Vandermeer HJ, Breekveldt ECH, de Jonge L, Toes-Zoutendijk E, Kooyker A, Nieboer D, Ramakers CR, Spaander MCW, van Vuuren AJ, Kuipers EJ, van Kemenade FJ, Nagtegaal ID, Dekker E, van Leerdam ME, Lansdorp-Vogelaar I; Dutch colorectal cancer screening working group. Meester RGS, et al. Among authors: ramakers cr. Gut. 2023 Jan;72(1):101-108. doi: 10.1136/gutjnl-2022-327188. Epub 2022 May 10. Gut. 2023. PMID: 35537811 Free PMC article.
Advanced serrated polyps as a target of screening: detection rate and positive predictive value within a fecal immunochemical test-based colorectal cancer screening population.
van Toledo DEFWM, Breekveldt ECH, IJspeert JEG, van Vuuren AJ, van Kemenade FJ, Ramakers C, Nagtegaal ID, van Leerdam ME, Spaander MCW, Lansdorp-Vogelaar I, Toes-Zoutendijk E, Dekker E. van Toledo DEFWM, et al. Among authors: ramakers c. Endoscopy. 2023 Jun;55(6):526-534. doi: 10.1055/a-1971-3488. Epub 2022 Nov 2. Endoscopy. 2023. PMID: 36323332
Factors associated with interval colorectal cancer after negative FIT: Results of two screening rounds in the Dutch FIT-based CRC screening program.
Breekveldt ECH, Toes-Zoutendijk E, van de Schootbrugge-Vandermeer HJ, de Jonge L, Kooyker AI, Spaander MCW, van Vuuren AJ, van Kemenade FJ, Ramakers C, Dekker E, Nagtegaal ID, van Leerdam ME, Lansdorp-Vogelaar I. Breekveldt ECH, et al. Among authors: ramakers c. Int J Cancer. 2023 Apr 15;152(8):1536-1546. doi: 10.1002/ijc.34373. Epub 2022 Dec 1. Int J Cancer. 2023. PMID: 36444504 Free PMC article.
66 results